Judge rejects bid for mistrial in Shkreli fraud case after lawyer blasts negative press coverage

Martin Shkreli denies allegations he ripped off millions of dollars from the drug company Retrophin to repay defrauded investors in his hedge funds.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.